Association of Secondhand Smoke Exposure with Pediatric Invasive Bacterial Disease and Bacterial Carriage: A Systematic Review and Meta-analysis
Background:
A number of epidemiologic studies have observed an association between secondhand smoke (SHS) exposure and pediatric invasive bacterial disease (IBD) but the evidence has not been systematically reviewed. We carried out a systematic review and meta-analysis of SHS exposure and two outcomes, IBD and pharyngeal carriage of bacteria, for Neisseria meningitidis (N. meningitidis), Haemophilus influenzae type B (Hib), and Streptococcus pneumoniae (S. pneumoniae).
Methods and Findings:
Two independent reviewers searched Medline, EMBASE, and selected other databases, and screened articles for inclusion and exclusion criteria. We identified 30 case-control studies on SHS and IBD, and 12 cross-sectional studies on SHS and bacterial carriage. Weighted summary odd ratios (ORs) were calculated for each outcome and for studies with specific design and quality characteristics. Tests for heterogeneity and publication bias were performed. Compared with those unexposed to SHS, summary OR for SHS exposure was 2.02 (95% confidence interval [CI] 1.52–2.69) for invasive meningococcal disease, 1.21 (95% CI 0.69–2.14) for invasive pneumococcal disease, and 1.22 (95% CI 0.93–1.62) for invasive Hib disease. For pharyngeal carriage, summary OR was 1.68 (95% CI, 1.19–2.36) for N. meningitidis, 1.66 (95% CI 1.33–2.07) for S. pneumoniae, and 0.96 (95% CI 0.48–1.95) for Hib. The association between SHS exposure and invasive meningococcal and Hib diseases was consistent regardless of outcome definitions, age groups, study designs, and publication year. The effect estimates were larger in studies among children younger than 6 years of age for all three IBDs, and in studies with the more rigorous laboratory-confirmed diagnosis for invasive meningococcal disease (summary OR 3.24; 95% CI 1.72–6.13).
Conclusions:
When considered together with evidence from direct smoking and biological mechanisms, our systematic review and meta-analysis indicates that SHS exposure may be associated with invasive meningococcal disease. The epidemiologic evidence is currently insufficient to show an association between SHS and invasive Hib disease or pneumococcal disease. Because the burden of IBD is highest in developing countries where SHS is increasing, there is a need for high-quality studies to confirm these results, and for interventions to reduce exposure of children to SHS.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Association of Secondhand Smoke Exposure with Pediatric Invasive Bacterial Disease and Bacterial Carriage: A Systematic Review and Meta-analysis. PLoS Med 7(12): e32767. doi:10.1371/journal.pmed.1000374
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000374
Souhrn
Background:
A number of epidemiologic studies have observed an association between secondhand smoke (SHS) exposure and pediatric invasive bacterial disease (IBD) but the evidence has not been systematically reviewed. We carried out a systematic review and meta-analysis of SHS exposure and two outcomes, IBD and pharyngeal carriage of bacteria, for Neisseria meningitidis (N. meningitidis), Haemophilus influenzae type B (Hib), and Streptococcus pneumoniae (S. pneumoniae).
Methods and Findings:
Two independent reviewers searched Medline, EMBASE, and selected other databases, and screened articles for inclusion and exclusion criteria. We identified 30 case-control studies on SHS and IBD, and 12 cross-sectional studies on SHS and bacterial carriage. Weighted summary odd ratios (ORs) were calculated for each outcome and for studies with specific design and quality characteristics. Tests for heterogeneity and publication bias were performed. Compared with those unexposed to SHS, summary OR for SHS exposure was 2.02 (95% confidence interval [CI] 1.52–2.69) for invasive meningococcal disease, 1.21 (95% CI 0.69–2.14) for invasive pneumococcal disease, and 1.22 (95% CI 0.93–1.62) for invasive Hib disease. For pharyngeal carriage, summary OR was 1.68 (95% CI, 1.19–2.36) for N. meningitidis, 1.66 (95% CI 1.33–2.07) for S. pneumoniae, and 0.96 (95% CI 0.48–1.95) for Hib. The association between SHS exposure and invasive meningococcal and Hib diseases was consistent regardless of outcome definitions, age groups, study designs, and publication year. The effect estimates were larger in studies among children younger than 6 years of age for all three IBDs, and in studies with the more rigorous laboratory-confirmed diagnosis for invasive meningococcal disease (summary OR 3.24; 95% CI 1.72–6.13).
Conclusions:
When considered together with evidence from direct smoking and biological mechanisms, our systematic review and meta-analysis indicates that SHS exposure may be associated with invasive meningococcal disease. The epidemiologic evidence is currently insufficient to show an association between SHS and invasive Hib disease or pneumococcal disease. Because the burden of IBD is highest in developing countries where SHS is increasing, there is a need for high-quality studies to confirm these results, and for interventions to reduce exposure of children to SHS.
: Please see later in the article for the Editors' Summary
Zdroje
1. BerkleyJA
LoweBS
MwangiI
WilliamsT
BauniE
2005
Bacteremia among children admitted to a rural hospital in Kenya.
N Engl J Med
352
39
47
2. BrentAJ
AhmedI
NdirituM
LewaP
NgetsaC
2006
Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study.
Lancet
367
482
488
3. HarrisonLH
BroomeCV
HightowerAW
1989
Haemophilus influenzae type b polysaccharide vaccine: an efficacy study. Haemophilus Vaccine Efficacy Study Group.
Pediatrics
84
255
261
4. KaijalainenT
KharitSM
KvetnayaAS
SirkiaK
HervaE
2008
Invasive infections caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae among children in St Petersburg, Russia.
Clin Microbiol Infect
14
507
510
5. MulhollandEK
AdegbolaRA
2005
Bacterial infections–a major cause of death among children in Africa.
N Engl J Med
352
75
77
6. O'BrienKL
WolfsonLJ
WattJP
HenkleE
Deloria-KnollM
2009
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.
Lancet
374
893
902
7. WattJP
WolfsonLJ
O'BrienKL
HenkleE
Deloria-KnollM
2009
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.
Lancet
374
903
911
8. World Health Organization
2005
Make every mother and child count.
Geneva
World Health Organization
9. HarrisonLH
TrotterCL
RamsayME
2009
Global epidemiology of meningococcal disease.
Vaccine
27
Suppl 2
B51
63
10. California Environmental Protection Agency
2005
Proposed Identification of Environmental Tobacco Smoke as a TAC; Office of Environmental Health Hazard Assessment CEPA, editor.
Sacramento
California Environmental Protection Agency
11. Office of the Surgeon General
2006
The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General; Department of Health and Human Services C, editor.
Atlanta (Georgia)
Office of the Surgeon General
12. BogaertD
De GrootR
HermansPW
2004
Streptococcus pneumoniae colonization: the key to pneumococcal disease.
Lancet Infect Dis
4
144
154
13. GrayBM
ConverseGMIII
DillonHCJr
1980
Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.
J Infect Dis
142
923
933
14. Lloyd-EvansN
O'DempseyTJ
BaldehI
SeckaO
DembaE
1996
Nasopharyngeal carriage of pneumococci in Gambian children and in their families.
Pediatr Infect Dis J
15
866
871
15. van der PollT
OpalSM
2009
Pathogenesis, treatment, and prevention of pneumococcal pneumonia.
Lancet
374
1543
1556
16. van DeurenM
BrandtzaegP
van der MeerJW
2000
Update on meningococcal disease with emphasis on pathogenesis and clinical management.
Clin Microbiol Rev
13
144
166, table of contents
17. VergnanoS
SharlandM
KazembeP
MwansamboC
HeathPT
2005
Neonatal sepsis: an international perspective.
Arch Dis Child Fetal Neonatal Ed
90
F220
F224
18. MoherD
LiberatiA
TetzlaffJ
AltmanDG
2009
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
Ann Intern Med
151
264
269, W264
19. HigginsJP
ThompsonSG
DeeksJJ
AltmanDG
2003
Measuring inconsistency in meta-analyses.
BMJ
327
557
560
20. DerSimonianR
LairdN
1986
Meta-analysis in clinical trials.
Control Clin Trials
7
177
188
21. HigginsJP
ThompsonSG
2002
Quantifying heterogeneity in a meta-analysis.
Stat Med
21
1539
1558
22. GalbraithRF
1988
A note on graphical presentation of estimated odds ratios from several clinical trials.
Stat Med
7
889
894
23. DuvalS
TweedieR
2000
Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.
Biometrics
56
455
463
24. EggerM
Davey SmithG
SchneiderM
MinderC
1997
Bias in meta-analysis detected by a simple, graphical test.
BMJ
315
629
634
25. BakerM
McNicholasA
GarrettN
JonesN
StewartJ
2000
Household crowding a major risk factor for epidemic meningococcal disease in Auckland children.
Pediatr Infect Dis J
19
983
990
26. CoenPG
TullyJ
StuartJM
AshbyD
VinerRM
2006
Is it exposure to cigarette smoke or to smokers which increases the risk of meningococcal disease in teenagers?
Int J Epidemiol
35
330
336
27. FischerM
HedbergK
CardosiP
PlikaytisBD
HoeslyFC
1997
Tobacco smoke as a risk factor for meningococcal disease.
Pediatr Infect Dis J
16
979
983
28. GreinT
O'FlanaganD
2001
Day-care and meningococcal disease in young children.
Epidemiol Infect
127
435
441
29. HanebergB
TonjumT
RodahlK
Gedde-DahlTW
1983
Factors preceding the onset of meningococcal disease, with special emphasis on passive smoking, symptoms of ill health.
NIPH Ann
6
169
173
30. HodgsonA
SmithT
GagneuxS
AdjuikM
PluschkeG
2001
Risk factors for meningococcal meningitis in northern Ghana.
Trans R Soc Trop Med Hyg
95
477
480
31. HonishL
SoskolneCL
SenthilselvanA
HoustonS
2008
Modifiable risk factors for invasive meningococcal disease during an Edmonton, Alberta outbreak, 1999-2002.
Can J Public Health
99
46
51
32. KrizP
BobakM
KrizB
2000
Parental smoking, socioeconomic factors, and risk of invasive meningococcal disease in children: a population based case-control study.
Arch Dis Child
83
117
121
33. McCallBJ
NeillAS
YoungMM
2004
Risk factors for invasive meningococcal disease in southern Queensland, 2000-2001.
Intern Med J
34
464
468
34. MoodleyJR
CoetzeeN
HusseyG
1999
Risk factors for meningococcal disease in Cape Town.
S Afr Med J
89
56
59
35. O'DempseyTJ
McArdleTF
MorrisJ
Lloyd-EvansN
BaldehI
1996
A study of risk factors for pneumococcal disease among children in a rural area of west Africa.
Int J Epidemiol
25
885
893
36. PereiroI
Diez-DomingoJ
SegarraL
BallesterA
AlbertA
2004
Risk factors for invasive disease among children in Spain.
J Infect
48
320
329
37. RobinsonP
TaylorK
NolanT
2001
Risk-factors for meningococcal disease in Victoria, Australia, in 1997.
Epidemiol Infect
127
261
268
38. SørensenHT
LabouriauR
JensenES
MortensenPB
SchønheyderHC
2004
Fetal growth, maternal prenatal smoking, and risk of invasive meningococcal disease: a nationwide case-control study.
Int J Epidemiol
33
816
820
39. Stanwell-SmithRE
StuartJM
HughesAO
RobinsonP
GriffinMB
1994
Smoking, the environment and meningococcal disease: a case control study.
Epidemiol Infect
112
315
328
40. StuartJM
CartwrightKA
DawsonJA
RickardJ
NoahND
1988
Risk factors for meningococcal disease: a case control study in south west England.
Community Med
10
139
146
41. TullyJ
VinerRM
CoenPG
StuartJM
ZambonM
2006
Risk and protective factors for meningococcal disease in adolescents: matched cohort study.
BMJ
445
450
42. HaddadMB
PorucznikCA
JoyceKE
DeAK
PaviaAT
2008
Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996-2002.
Ann Epidemiol
18
139
146
43. TakalaAK
JeroJ
KelaE
RonnbergPR
KoskenniemiE
1995
Risk factors for primary invasive pneumococcal disease among children in Finland.
JAMA
273
859
864
44. ArnoldC
MakintubeS
IstreGR
1993
Day care attendance and other risk factors for invasive Haemophilus influenzae type b disease.
Am J Epidemiol
138
333
340
45. CochiSL
FlemingDW
HightowerAW
LimpakarnjanaratK
FacklamRR
1986
Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors.
J Pediatr
108
887
896
46. TakalaAK
EskolaJ
PalmgrenJ
RonnbergPR
KelaE
1989
Risk factors of invasive Haemophilus influenzae type b disease among children in Finland.
J Pediatr
115
694
701
47. VadheimCM
GreenbergDP
BordenaveN
ZiontzL
ChristensonP
1992
Risk factors for invasive Haemophilus influenzae type b in Los Angeles County children 18-60 months of age.
Am J Epidemiol
136
221
235
48. FogartyJ
MoloneyAC
NewellJB
1995
The epidemiology of Haemophilus influenzae type b disease in the Republic of Ireland.
Epidemiol Infect
114
451
463
49. JafariHS
AdamsWG
RobinsonKA
PlikaytisBD
WengerJD
1999
Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group.
Am J Public Health
89
364
368
50. McVernonJ
AndrewsN
SlackM
MoxonR
RamsayM
2008
Host and environmental factors associated with Hib in England, 1998-2002.
Arch Dis Child
93
670
675
51. MuhlemannK
AlexanderER
WeissNS
PepeM
SchopferK
1996
Risk factors for invasive Haemophilus influenzae disease among children 2-16 years of age in the vaccine era, Switzerland 1991-1993. The Swiss H. Influenzae Study Group.
Int J Epidemiol
25
1280
1285
52. SilfverdalSA
BodinL
HugossonS
GarpenholtO
WernerB
1997
Protective effect of breastfeeding on invasive Haemophilus influenzae infection: a case-control study in Swedish preschool children.
Int J Epidemiol
26
443
450
53. WolffMC
MoultonLH
NewcomerW
ReidR
SantoshamM
1999
A case-control study of risk factors for Haemophilus influenzae type B disease in Navajo children.
Am J Trop Med Hyg
60
263
266
54. DaviesAL
O'FlanaganD
SalmonRL
ColemanTJ
1996
Risk factors for Neisseria meningitidis carriage in a school during a community outbreak of meningococcal infection.
Epidemiol Infect
117
259
266
55. KremastinouJ
BlackwellC
TzanakakiG
KallergiC
EltonR
1994
Parental smoking and carriage of Neisseria meningitidis among Greek schoolchildren.
Scand J Infect Dis
26
719
723
56. KremastinouJ
TzanakakiG
VelonakisE
VoyiatziA
NickolaouA
1999
Carriage of Neisseria meningitidis and Neisseria lactamica among ethnic Greek school children from Russian immigrant families in Athens.
FEMS Immunol Med Microbiol
23
13
20
57. MacLennanJ
KafatosG
NealK
AndrewsN
CameronJC
2006
Social behavior and meningococcal carriage in British teenagers.
Emerg Infect Dis
12
950
957
58. StuartJM
CartwrightKA
RobinsonPM
NoahND
1989
Effect of smoking on meningococcal carriage.
Lancet
2
723
725
59. CardozoDM
Nascimento-CarvalhoCM
AndradeAL
Silvany-NetoAM
DaltroCH
2008
Prevalence and risk factors for nasopharyngeal carriage of Streptococcus pneumoniae among adolescents.
J Med Microbiol
57
185
189
60. ColesCL
KanungoR
RahmathullahL
ThulasirajRD
KatzJ
2001
Pneumococcal nasopharyngeal colonization in young South Indian infants.
Pediatr Infect Dis J
20
289
295
61. GreenbergD
Givon-LaviN
BroidesA
BlancovichI
PeledN
2006
The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers.
Clin Infect Dis
42
897
903
62. LaboutJA
DuijtsL
ArendsLR
JaddoeVW
HofmanA
2008
Factors associated with pneumococcal carriage in healthy Dutch infants: the generation R study.
J Pediatr
153
771
776
63. SungRY
LingJM
FungSM
OppenheimerSJ
CrookDW
1995
Carriage of Haemophilus influenzae and Streptococcus pneumoniae in healthy Chinese and Vietnamese children in Hong Kong.
Acta Paediatr
84
1262
1267
64. AyyildizA
AktasAE
YazgiH
2003
Nasopharyngeal carriage rate of Haemophilus influenzae in children aged 7-12 years in Turkey.
Int J Clin Pract
57
686
688
65. Oguzkaya-ArtanM
BaykanZ
ArtanC
2008
Nasal carriage of Staphylococcus aureus in healthy preschool children.
Jpn J Infect Dis
61
70
72
66. NuortiJP
ButlerJC
FarleyMM
HarrisonLH
McGeerA
2000
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team.
N Engl J Med
342
681
689
67. DyeJA
AdlerKB
1994
Effects of cigarette smoke on epithelial cells of the respiratory tract.
Thorax
49
825
834
68. WannerA
SalathéM
O'RiordanTG
1996
Mucociliary clearance in the airways.
Am J Respir Crit Care Med
154
1868
1902
69. ArcaviL
BenowitzNL
2004
Cigarette smoking and infection.
Arch Intern Med
164
2206
2216
70. GaschlerGJ
ZavitzCC
BauerCM
SkrticM
LindahlM
2008
Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages.
Am J Respir Cell Mol Biol
38
218
226
71. GreenRM
GallyF
KeeneyJG
AlperS
GaoB
2009
Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model.
PLoS One
4
e6860
doi:10.1371/journal.pone.0006860
72. Martí-LliterasP
RegueiroV
MoreyP
HoodDW
SausC
2009
Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke.
Infect Immun
77
4232
4242
73. SorensenHT
LabouriauR
JensenES
MortensenPB
SchonheyderHC
2004
Fetal growth, maternal prenatal smoking, and risk of invasive meningococcal disease: a nationwide case-control study.
Int J Epidemiol
33
816
820
74. YusufHR
RochatRW
BaughmanWS
GargiulloPM
PerkinsBA
1999
Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996.
Am J Public Health
89
712
717
75. MorenoSG
SuttonAJ
TurnerEH
AbramsKR
CooperNJ
2009
Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications.
BMJ
339
b2981
76. Centers for Disease Control and Prevention (CDC)
2005
Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease–United States, 1998-2003.
MMWR Morb Mortal Wkly Rep
54
893
897
77. De WalsP
DeceuninckG
BoulianneN
De SerresG
2004
Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine.
JAMA
292
2491
2494
78. LevineOS
O'BrienKL
KnollM
AdegbolaRA
BlackS
2006
Pneumococcal vaccination in developing countries.
Lancet
367
1880
1882
79. LimSS
SteinDB
CharrowA
MurrayCJ
2008
Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage.
Lancet
372
2031
2046
80. MorrisSK
MossWJ
HalseyN
2008
Haemophilus influenzae type b conjugate vaccine use and effectiveness.
Lancet Infect Dis
8
435
443
81. MadhiSA
AdrianP
KuwandaL
CutlandC
AlbrichWC
2007
Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae–and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization–in HIV-Infected and HIV-uninfected children.
J Infect Dis
196
1662
1666
82. MadhiSA
AdrianP
KuwandaL
JassatW
JonesS
2007
Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.
Vaccine
25
2451
2457
83. ObaroSK
AdegbolaRA
BanyaWA
GreenwoodBM
1996
Carriage of pneumococci after pneumococcal vaccination.
Lancet
348
271
272
84. World Health Organization
2009
WHO Report on the Global Tobacco Epidemic: implementing smoke-free environments.
Geneva
World Health Organization
85. JhaP
ChaloupkaFJ
2000
Tobacco control in developing countries.
Oxford
Oxford University Press
86. LightwoodJM
GlantzSA
2009
Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke.
Circulation
120
1373
1379
87. SargentRP
ShepardRM
GlantzSA
2004
Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study.
BMJ
328
977
980
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 12
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study
- Participatory Epidemiology: Use of Mobile Phones for Community-Based Health Reporting
- Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis
- Toward a Consensus on Guiding Principles for Health Systems Strengthening